Evidence map›Paper›PMID 24920698›Full record

ArticleCirculation research2014

Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation.

Julie K Freed, Andreas M Beyer, John A LoGiudice, Joseph C Hockenberry, David D Gutterman

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05107869 (Effect of Plasma Ceramides on Peripheral Vascular Function), which is not on this map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05107869 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Plasma Ceramides on Peripheral Vascular Function

TypeinterventionalSponsorMedical College of WisconsinRan2023 to 2026Enrolled23ConditionsPeripheral Vascular Disease, Lipid Disorder, Endothelial DysfunctionArmsHigh Saturated Fat
3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 138 citations in OpenAlex.

  1. Trial
  2. Article
  3. Sphingolipids and Atherosclerosis.Current atherosclerosis reports · 2026
    Review
  4. Review
  5. Guidelines for evaluating endothelial function in vascular tissue.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy.International journal of molecular sciences · 2025
    Review
  14. Cystathionine γ lyase deletion enhances corpus cavernosum contraction via thromboxane AAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Article
  15. Article
  16. Endothelial TERT drives microvascular phenotype associated with coronary artery disease.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  17. Article
  18. A chronology of basic and clinical research in the coronary microcirculation.Journal of molecular and cellular cardiology · 2025
    Article
  19. Sexually dimorphic mechanisms of HJournal of applied physiology (Bethesda, Md. : 1985) · 2025
    Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Julie K FreedFrom the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.).
Andreas M BeyerFrom the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.).
John A LoGiudiceFrom the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.).
Joseph C HockenberryFrom the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.).
David D GuttermanFrom the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.). dgutt@mcw.edu.
Medical College of Wisconsin · US

Funding

Mechanism of Flow-Induced Dilation in the Human MicrocirculationR01HL113612 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI GUTTERMAN, DAVID D. · 2013 to 2016
$1.7M
Role of Hydrogen Peroxide in the Mechanism of Flow-Induced Dilation of the Human R01HL094971 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI GUTTERMAN, DAVID D. · 2009 to 2012
$1.5M
Anesthesiology Research Training ProgramT32GM089586 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI EBERT, THOMAS JAY · 2010 to 2019
$1.5M
MECHANISMS OF HUMAN CORONARY ARTERIOLAR DILATIONR01HL062852 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI GUTTERMAN, DAVID D. · 1998 to 2001
$415k
NHLBI NIH HHS R01 HL094971NHLBI NIH HHS R01 HL113612NHLBI NIH HHS R01 HL113612-02NIGMS NIH HHS T32 GM089586
6 · The paper itself

Abstract

rationaleMitochondrial-derived hydrogen peroxide (H2O2) regulates flow-induced dilation (FID) in microvessels from patients with coronary artery disease. The relationship between ceramide, an independent risk factor for coronary artery disease and a known inducer of mitochondrial reactive oxygen species, and FID is unknown.

objectiveWe examined the hypothesis that exogenous ceramide induces a switch in the mediator of FID from nitric oxide to H2O2. METHODS AND

resultsInternal diameter changes of resistance arterioles from human adipose and atrial tissue were measured by video microscopy. Mitochondrial H2O2 production was assayed in arterioles using mito peroxy yellow 1. Polyethylene glycol-catalase, rotenone, and Mito-TEMPO impaired FID in healthy adipose arterioles pretreated with ceramide, whereas N(ω)-nitro-l-arginine methyl ester had no effect. Mitochondrial H2O2 production was induced in response to flow in healthy adipose vessels pretreated with ceramide, and this was abolished in the presence of polyethylene glycol-catalase. Immunohistochemistry demonstrated ceramide accumulation in arterioles from both healthy patients and patients with coronary artery disease. N(ω)-nitro-l-arginine methyl ester reduced vasodilation to flow in adipose as well as atrial vessels from patients with coronary artery disease incubated with GW4869, a neutral sphingomyelinase inhibitor, whereas polyethylene glycol-catalase had no effect.

conclusionsOur data indicate that ceramide has an integral role in the transition of the mediator of FID from nitric oxide to mitochondrial-derived H2O2 and that inhibition of ceramide production can revert the mechanism of dilation back to nitric oxide. Ceramide may be an important target for preventing and treating vascular dysfunction associated with atherosclerosis.

Indexed as

Adipose TissueAdultAgedAntioxidantsArteriolesCase-Control StudiesCoronary Artery DiseaseCoronary CirculationCoronary VesselsEnzyme InhibitorsFemaleHumansHydrogen PeroxideMaleMicrocirculationMicroscopy, VideoAntioxidantsEnzyme InhibitorsHydrogen PeroxideN-acetylsphingosineNitric OxideNitric Oxide SynthaseSphingomyelin PhosphodiesteraseSphingosineceramidesmitochondrianitric oxidereactive oxygen speciessphingomyelin phosphodiesterase

Identifiers

PMID24920698
PMCPMC4640193
OpenAlexW2078653194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.